Ionis Pharmaceuticals in (ions 1.75 06/15/28)
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 6 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 1 sold out. The largest holders were Lombard Odier Asset Management (Europe) Ltd ($14.8M), Sonora Investment Management Group, LLC ($7.3M) and State of Wisconsin Investment Board ($4.1M).
- Company
- Ionis Pharmaceuticals in (ions 1.75 06/15/28)
- CUSIP
- 462222AF7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $14.8M |
| Exits | 1 | $8.5M |
All 13F filers, Q2 2025 → Q3 2025: 1,090,993 shares bought and 8,110,000 shares sold, net −7,019,007 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Lombard Odier Asset Management (Europe) Ltd | 1.10% | New | 72,902 | $14.8M |
| Sonora Investment Management Group, LLC | 0.51% | Reduce -0.0% | 5,283,000 | $7.3M |
| State of Wisconsin Investment Board | 0.01% | Add +50.0% | 3,000,000 | $4.1M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,500,000 | $3.4M |
| Nomura Holdings Inc. | 0.02% | Add +52.9% | 52,318 | $3.4M |
| Sei Investments Co. | 0.00% | No change | 262,000 | $362K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.